Clinical Research Coordinator
The START Center for Cancer Research
Summary
The Clinical Research Coordinator (CRC) will work under the guidance of senior research staff to support the daily activities of early phase oncology clinical trials. The CRC ensures the accurate and timely conduct of clinical research, adhering to protocols, regulatory requirements, and patient safety standards. This role involves direct patient interaction, data collection, and maintaining compliance with Good Clinical Practice (GCP).
Job description
Essential Responsibilities
- Communicate on a regular basis with Study Sponsors, CROs, staff, etc. regarding questions, concerns, as well as status of the protocol.
- Monitor the overall day-to-day conduct of assigned studies in accordance with the specified protocol requirements, Standard Operating Procedures, and Good Clinical Practice to ensure integrity regarding all aspects of the study.
- Create/review forms created or revised for assigned trials to assure protocol compliance.
- Assist with patient screening and determination of eligibility.
- Facilitate the informed consent process ensuring that consent is appropriately completed.
- Prepare and manage source documents according to standard operating procedures.
- Recognize deviations to the protocol and work with leadership and staff to address corrective actions to prevent deviations.
- Work with the Principal Investigator to complete and submit Serious Adverse Event reports.
- Perform protocol specific closeout related activities in conjunction with the data coordinator.
- Provide documentation for all deviations whether related to the protocol or a SOP.
Required Education and Experience
- High School Diploma or GED.
- 2 years of clinical research experience.
- Basic understanding of oncology clinical trials, particularly Phase 1 studies.
- Strong attention to detail and accuracy in data collection and documentation.
- Ability to manage multiple tasks and meet deadlines in a fast-paced environment.
- Working knowledge of GCP and regulatory requirements.
- Proficient in Microsoft Office Suite and clinical trial management software.
Preferred Education and Experience
- Experience working in an oncology setting.
Requirements
- High School Diploma or GED
- 2 years of clinical research experience
- Basic understanding of oncology clinical trials, particularly Phase 1 studies
- Strong attention to detail and accuracy in data collection and documentation
- Ability to manage multiple tasks and meet deadlines in a fast-paced environment
- Working knowledge of GCP and regulatory requirements
- Proficient in Microsoft Office Suite and clinical trial management software
- Experience working in an oncology setting (preferred)
Benefits
- 401(k) Matching
- Annual Performance Bonus
- Paid Time Off
- Paid Holidays
- Medical, Dental & Vision
- Life Insurance
- Disability Insurance
- Employee Assistance Program
- Flexible FSA
- HSA Plans
Company overview
The START Center for Cancer Research (START) is a global leader in early-phase oncology clinical trials, providing specialized access to novel anti-cancer therapies through its extensive network of community-based research sites. Founded in Texas in 2007, START has established itself as the world's largest community-based early-phase oncology research organization with operations spanning the United States and Europe. The company operates 10 research locations globally and has conducted over 1,500 early-phase clinical trials, contributing to the development and approval of 45 FDA/EMA-approved cancer therapies. START's unique model embeds clinical trial capabilities within community oncology centers, enabling patients to access cutting-edge treatments where they already receive care. With more than 30 Principal Investigators and over 100,000 square feet of world-class research facilities, the organization focuses on accelerating the transition from clinical trials to approved treatments. START's comprehensive approach includes genetic tumor profiling, targeted therapies, and multi-specialty services, all delivered through a patient-centered framework that prioritizes accessibility and scientific rigor in cancer research.